Dalvie, Neil C.
Brady, Joseph R.
Crowell, Laura E.
Tracey, Mary Kate
Biedermann, Andrew M.
Kaur, Kawaljit
Hickey, John M.
Kristensen, D. Lee II
Bonnyman, Alexandra D.
Rodriguez-Aponte, Sergio A.
Whittaker, Charles A.
Bok, Marina
Vega, Celina
Mukhopadhyay, Tarit K.
Joshi, Sangeeta B.
Volkin, David B.
Parreño, Viviana
Love, Kerry R.
Love, J. Christopher http://orcid.org/0000-0003-0921-3144
Funding for this research was provided by:
Bill & Melinda Gates Foundation (INV-008547)
National Institutes of Health (P30‐CA14051, 2T32GM008334)
Article History
Received: 18 November 2020
Accepted: 21 April 2021
First Online: 1 May 2021
Declarations
:
: Animal studies were reviewed and approved by The Institutional Committee for the Care and Use of Experimental Animals at INTA CICVyA, Argentina, evaluation request number 55/2018, “Immunogenic quality control of subunit vaccines for human rotavirus in guinea pigs.”
: Not applicable.
: L.E.C., K.R.L., and J.C.L. have filed patents related to the InSCyT system and methods. K.R.L. and J.C.L. are co-founders and consultants to Sunflower Therapeutics PBC.